🔗 Permalink

Inventor profile of:

Joel McIntosh

City:

Pacifica, California

Country:

United States

Published Applications:

Last publication date:

2026-03-19

Top Assignees for applications by Joel McIntosh

The entities that hold a legal rights for patent applications filed by inventor McIntosh Joel:

Amgen Inc. 6 Thousand Oaks, CA United States
Roche Palo Alto LLC 4 Palo Alto, CA United States
Roche Palo Alto LLC 2 San Francisco, CA United States
The Regents of the University of California 2 Oakland, CA United States
Roche Palo Alto 1 Palo Alto, CA United States

Recent patent applications by McIntosh Joel

Joel McIntosh from Pacifica, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-03-19

US20260078091A1

Chemistry; metallurgy

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer

#2 | 2024-09-12

US20240300892A1

Chemistry; metallurgy

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer

#3 | 2021-06-17

US20210179560A1

Chemistry; metallurgy

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer

#4 | 2019-05-16

US20190144386A1

Chemistry; metallurgy

Inhibitors of integrin alpha 5 beta 1 and methods of use

#5 | 2019-02-28

US20190062276A1

Chemistry; metallurgy

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer

#6 | 2017-05-25

US20170144971A1

Chemistry; metallurgy

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer

#7 | 2016-09-15

US20160264566A1

Chemistry; metallurgy

Anti-alphavbeta1 integrin inhibitors and methods of use

#8 | 2016-05-19

US20160137667A1

Chemistry; metallurgy

Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer

#9 | 2014-10-23

US20140315895A1

Chemistry; metallurgy

Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer

#10 | 2014-08-21

US20140235629A1

Chemistry; metallurgy

Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer

#11 | 2014-07-10

US20140194413A1

Chemistry; metallurgy

Inhibitors of bruton's tyrosine kinase

#12 | 2014-01-09

US20140011796A1

Chemistry; metallurgy

PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER

#13 | 2012-05-24

US20120129845A1

Chemistry; metallurgy

Inhibitors of bruton's tyrosine kinase

#14 | 2011-12-29

US20110319378A1

Chemistry; metallurgy

Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer

#15 | 2011-05-05

US20110105479A1

Chemistry; metallurgy

Inhibitors of bruton's tyrosine kinase

#16 | 2010-04-22

US20100099659A1

Human necessities

Inhibitors of bruton's tyrosine kinase

#17 | 2009-12-24

US20090318448A1

Chemistry; metallurgy

Inhibitors of bruton's tyrosine kinase

#18 | 2009-12-10

US20090306041A1

Human necessities

Inhibitors of Bruton's tyrosine kinase

#19 | 2008-06-05

US20080132528A1

Chemistry; metallurgy

Kinase inhibitors and methods for using the same

InventorID:

606423 ⎘